Anshuman Srivastava

Anshuman Srivastava practices at Family HealthCare Network - Visalia (N Bridge St) in Visalia, California.

Anshuman Srivastava's NPI, 1083076475, was assigned on March 24, 2016. Anshuman Srivastava holds California license A159031.

Anshuman Srivastava's primary practice is Family HealthCare Network - Visalia (N Bridge St), at 501 North Bridge Street, Visalia, CA 93291 in Tulare County. The practice phone is (559) 734-1247.

Anshuman Srivastava's primary practice is Family HealthCare Network - Visalia (N Bridge St) in Visalia, California. The medical group on file is Family HealthCare Network. Dmand AI also links Anshuman Srivastava to 1 more group practice or clinic, named with a free account. Anshuman Srivastava's employer is on file too: a community health center (fqhc).

Dmand AI tracks the electronic health record (EHR) system at each site where Anshuman Srivastava practices, 2 sites in all. Vendor and product names are available with a free account.

Family medicine is Anshuman Srivastava's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Anshuman Srivastava is licensed in California.

CMS data shows 137 Medicare services from Anshuman Srivastava across 2 procedure codes in 2024, for 60 Medicare patients. Medicare paid $8,434 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 60 Medicare patients who saw Anshuman Srivastava in 2024. The largest group is 65 to 74, with 23 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 4.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Anshuman Srivastava's median patient age at 29, with 63% women.

In 2024, Anshuman Srivastava wrote 2,413 Medicare Part D claims for 254 patients. 81% of them were for generic drugs. CMS names the drug for 1,863 of them, across 50 drugs with 11 or more claims each, at $139,132 in total drug cost. In 2023, CMS named 2,040 claims across 59 drugs.

Anshuman Srivastava accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 18 papers to Anshuman Srivastava, published from 2016 to 2024. 2017 was the busiest year, with 3. The most frequent topics are Pesticide Residues, Solid Phase Extraction and Food Contamination. Anshuman Srivastava has published most often in Anal Bioanal Chem. Anshuman Srivastava's most frequent co-authors are Priya J. Bansal, MD, Arvind Kumar, MD and Mohammed Siddiqui, MD.

CMS Open Payments shows 12 general payments to Anshuman Srivastava from 8 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $286.